Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93.1M
-
Number of holders
-
227
-
Total 13F shares, excl. options
-
76.6M
-
Shares change
-
-342K
-
Total reported value, excl. options
-
$2.13B
-
Value change
-
-$35.5M
-
Put/Call ratio
-
1.23
-
Number of buys
-
107
-
Number of sells
-
-112
-
Price
-
$27.78
Significant Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q2 2019
297 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q2 2019.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 227 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 76.6M shares
of 93.1M outstanding shares and own 82.25% of the company stock.
Largest 10 shareholders include BlackRock Inc. (12.5M shares), BAILLIE GIFFORD & CO (9.53M shares), VANGUARD GROUP INC (8.32M shares), STATE STREET CORP (4.12M shares), D. E. Shaw & Co., Inc. (3.32M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (3.08M shares), DIMENSIONAL FUND ADVISORS LP (2.73M shares), DISCIPLINED GROWTH INVESTORS INC /MN (2.71M shares), Invesco Ltd. (1.86M shares), and NORTHERN TRUST CORP (1.8M shares).
This table shows the top 227 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.